Aehr Test Systems Management

Management criteria checks 3/4

Aehr Test Systems' CEO is Gayn Erickson, appointed in Jan 2012, has a tenure of 12.25 years. total yearly compensation is $1.65M, comprised of 21.1% salary and 78.9% bonuses, including company stock and options. directly owns 1.1% of the company’s shares, worth €3.60M. The average tenure of the management team and the board of directors is 2 years and 8.5 years respectively.

Key information

Gayn Erickson

Chief executive officer

US$1.7m

Total compensation

CEO salary percentage	21.1%
CEO tenure	12.3yrs
CEO ownership	1.1%
Management average tenure	2yrs
Board average tenure	8.5yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Gayn Erickson's remuneration changed compared to Aehr Test Systems's earnings?
Date	Total Compensation	Salary	Company Earnings
Feb 29 2024	n/a	n/a	US$15m
Nov 30 2023	n/a	n/a	US$21m
Aug 31 2023	n/a	n/a	US$19m
May 31 2023	US$2m	US$348k	US$15m
Feb 28 2023	n/a	n/a	US$14m
Nov 30 2022	n/a	n/a	US$12m
Aug 31 2022	n/a	n/a	US$9m
May 31 2022	US$4m	US$299k	US$9m
Feb 28 2022	n/a	n/a	US$4m
Nov 30 2021	n/a	n/a	US$1m
Aug 31 2021	n/a	n/a	-US$1m
May 31 2021	US$485k	US$225k	-US$2m
Feb 28 2021	n/a	n/a	-US$5m
Nov 30 2020	n/a	n/a	-US$4m
Aug 31 2020	n/a	n/a	-US$2m
May 31 2020	US$533k	US$289k	-US$3m
Feb 29 2020	n/a	n/a	US$193k
Nov 30 2019	n/a	n/a	-US$3m
Aug 31 2019	n/a	n/a	-US$4m
May 31 2019	US$481k	US$289k	-US$5m
Feb 28 2019	n/a	n/a	-US$5m
Nov 30 2018	n/a	n/a	-US$2m
Aug 31 2018	n/a	n/a	-US$997k
May 31 2018	US$452k	US$288k	US$528k
Feb 28 2018	n/a	n/a	-US$458k
Nov 30 2017	n/a	n/a	-US$3m
Aug 31 2017	n/a	n/a	-US$5m
May 31 2017	US$438k	US$275k	-US$6m

Compensation vs Market: Gayn's total compensation ($USD1.65M) is above average for companies of similar size in the German market ($USD1.04M).

Compensation vs Earnings: Gayn's compensation has been consistent with company performance over the past year.

CEO

Gayn Erickson (59 yo)

12.3yrs

Tenure

US$1,652,788

Compensation

Mr. Gayn Erickson has been the Chief Executive Officer and President of Aehr Test Systems since January 3, 2012 and has been its Director since January 2012. Mr. Erickson a 23-year veteran of the semicondu...

Leadership Team

Name	Position	Tenure	Compensation	Ownership
Rhea Posedel	Founder & Independent Chairman	47.3yrs	US$239.06k	1.72% $ 5.6m
Gayn Erickson	President	12.3yrs	US$1.65m	1.1% $ 3.6m
Vernon Rogers	Executive Vice President of Sales & Marketing	5.5yrs	US$710.40k	0.044% $ 142.7k
Chris Siu	CFO, Executive VP of Finance & Secretary	less than a year	no data	0.011% $ 37.4k
Adil Engineer	Chief Operating Officer	2yrs	no data	0.012% $ 38.9k
Donald Richmond	Chief Technology Officer	less than a year	US$270.50k	0.54% $ 1.8m
Avijit Ray-Chaudhuri	Executive Vice President of R&D	less than a year	no data	0.038% $ 125.5k

2.0yrs

Average Tenure

57.5yo

Average Age

Experienced Management: AYB's management team is considered experienced (2 years average tenure).

Board Members

Name	Position	Tenure	Compensation	Ownership
Rhea Posedel	Founder & Independent Chairman	47.3yrs	US$239.06k	1.72% $ 5.6m
Gayn Erickson	President	12.3yrs	US$1.65m	1.1% $ 3.6m
Fariba Danesh	Independent Director	2.9yrs	US$174.50k	0.044% $ 143.6k
Howard Slayen	Independent Director	16.3yrs	US$180.75k	0.65% $ 2.1m
Laura Oliphant	Independent Director	4.8yrs	US$182.00k	0.044% $ 143.6k
Geoffrey Scott	Independent Director	3.6yrs	US$180.75k	0.82% $ 2.7m

8.5yrs

Average Tenure

69yo

Average Age

Experienced Board: AYB's board of directors are considered experienced (8.5 years average tenure).

Aehr Test Systems Management

Management criteria checks 3/4

Key information

Recent management updates

President recently sold €78k worth of stock

Aehr Test Systems Announces Resignation of Rhea J. Posedel from Corporate Governance and Nominating Committee

Aehr Test Systems, Annual General Meeting, Oct 23, 2023

President recently sold €5.7m worth of stock

Aehr Test Systems Appoints Chris Siu, as Chief Financial Officer Effective June 1, 2023

Independent Director recently sold €775k worth of stock

Recent updates

New major risk - Revenue and earnings growth

Now 25% overvalued

Third quarter 2024 earnings released: US$0.051 loss per share (vs US$0.15 profit in 3Q 2023)

Aehr Test Systems Provides Earnings Guidance for the Fiscal Year Ending May 31, 2024

Investor sentiment deteriorates as stock falls 16%

Aehr Test Systems to Report Q3, 2024 Results on Apr 09, 2024

Investor sentiment deteriorates as stock falls 16%

Investor sentiment improves as stock rises 17%

New minor risk - Insider selling

President recently sold €78k worth of stock

Second quarter 2024 earnings released: EPS: US$0.21 (vs US$0.14 in 2Q 2023)

Aehr Test Systems Provides Earnings Guidance for the Fiscal Year Ending May 31, 2024

Investor sentiment deteriorates as stock falls 16%

Aehr Test Systems Announces Resignation of Rhea J. Posedel from Corporate Governance and Nominating Committee

Investor sentiment deteriorates as stock falls 18%

First quarter 2024 earnings released: EPS: US$0.16 (vs US$0.022 in 1Q 2023)

Aehr Test Systems Reiterates Earnings Guidance for the Fiscal Year Ending May 31, 2024

Aehr Test Systems to Report Q1, 2024 Results on Oct 05, 2023

Aehr Test Systems, Annual General Meeting, Oct 23, 2023

Full year 2023 earnings released: EPS: US$0.52 (vs US$0.36 in FY 2022)

Investor sentiment deteriorates as stock falls 17%

President recently sold €5.7m worth of stock

Full year 2023 earnings released: EPS: US$0.52 (vs US$0.36 in FY 2022)

Aehr Test Systems Provides Earnings Guidance for the Year 2024

Aehr Test Systems to Report Q4, 2023 Results on Jul 13, 2023

Aehr Test Systems Appoints Chris Siu, as Chief Financial Officer Effective June 1, 2023

Investor sentiment improves as stock rises 19%

Investor sentiment deteriorates as stock falls 21%

Independent Director recently sold €775k worth of stock

Investor sentiment deteriorates as stock falls 26%

Third quarter 2023 earnings released: EPS: US$0.15 (vs US$0.083 in 3Q 2022)

Investor sentiment improves as stock rises 33%

Investor sentiment improves as stock rises 20%

Insider recently sold €1.2m worth of stock

Aehr Test Systems Announces Board Changes

Investor sentiment improves as stock rises 27%

Independent Director recently sold €381k worth of stock

Investor sentiment improved over the past week

Aehr Test Systems Reiterates Revenue Guidance for the Fiscal Year Ending May 31, 2023

Second quarter 2023 earnings released: EPS: US$0.14 (vs US$0.027 in 2Q 2022)

Aehr Test Systems to Report Q2, 2023 Results on Jan 05, 2023

President recently sold €1.7m worth of stock

Investor sentiment improved over the past week

Vice President of Engineering recently sold €463k worth of stock

Investor sentiment improved over the past week

First quarter 2023 earnings released: EPS: US$0.022 (vs US$0.029 in 1Q 2022)

Aehr Test Systems Provides Revenue Guidance for the Fiscal Year Ending May 31, 2023

Investor sentiment deteriorated over the past week

Aehr Test Systems, Annual General Meeting, Oct 18, 2022

Aehr Test Systems to Report Q1, 2023 Results on Oct 06, 2022

Investor sentiment deteriorated over the past week

Full year 2022 earnings released: EPS: US$0.36 (vs US$0.086 loss in FY 2021)

Investor sentiment improved over the past week

Independent Director recently sold €123k worth of stock

Investor sentiment improved over the past week

Full year 2022 earnings released: EPS: US$0.36 (vs US$0.086 loss in FY 2021)

Aehr Test Systems Provides Earnings Guidance for the Fiscal Year 2023

Aehr Test Systems to Report Fiscal Year 2022 Results on Jul 19, 2022

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Aehr Test Systems Appoints Adil Engineer as the Chief Operating Officer, Effective April 6, 2022

Third quarter 2022 earnings released: EPS: US$0.083 (vs US$0.031 loss in 3Q 2021)

Aehr Test Systems Reiterates Financial Guidance the Fiscal Year Ending May 31, 2022

Aehr Test Systems to Report Q3, 2022 Results on Mar 31, 2022

Vice President of Operations recently sold €133k worth of stock

Aehr Test Systems Reiterates Earnings Guidance for the Fiscal Year Ending May 31, 2022

Second quarter 2022 earnings: EPS in line with analyst expectations despite revenue beat

Independent Director recently sold €1.1m worth of stock

Independent Director recently sold €185k worth of stock